Position in GILD
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$493,736
-$50,921 QoQ
Shares Held
3,908
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#1,377
of 2,266 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Pekin Hardy Strauss, Inc. holds $25,845,902 across 12 Drug Manufacturers - General names. GILD ranks #9 (1.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
28,681 | $7,217,286 | |
| 2 | NVS |
Novartis AG
|
26,136 | $4,096,033 | |
| 3 | JNJ |
Johnson & Johnson
|
13,995 | $3,554,310 | |
| 4 | NVO |
Novo Nordisk A S
|
70,160 | $3,363,470 | |
| 5 | MRK |
Merck & Co., Inc.
|
24,621 | $3,163,798 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
23,721 | $1,366,804 | |
| 7 | LLY |
ELI LILLY & Co
|
971 | $1,164,646 | |
| 8 | AZN |
Astrazeneca PLC
|
3,262 | $618,540 |
All Filings in GILD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $493,736 | 3,908 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $544,657 | 3,908 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $487,646 | 3,973 | Shares | Sole | 2026-01-30 | |
| 2025-09-30 | $442,890 | 3,990 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $522,197 | 4,710 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $561,482 | 5,011 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $462,773 | 5,010 | Shares | Sole | 2025-02-04 | |
| 2024-09-30 | $526,515 | 6,280 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $380,579 | 5,547 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $414,009 | 5,652 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $457,868 | 5,652 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $423,560 | 5,652 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $435,599 | 5,652 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $475,584 | 5,732 | Shares | Sole | 2023-05-08 | |
| 2022-12-31 | $492,092 | 5,732 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $409,498 | 6,638 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $417,217 | 6,750 | Shares | Sole | 2022-08-05 | |
| 2022-03-31 | $401,287 | 6,750 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $562,727 | 7,750 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $618,172 | 8,850 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $613,198 | 8,905 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $729,026 | 11,280 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $694,400 | 11,919 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $689,339 | 10,909 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $920,587 | 11,965 | Shares | Sole | 2020-08-10 | |
| 2020-03-31 | $1,478,752 | 19,780 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||